Benzinga | Aug 12, 2021 05:13PM EDT

Onconova Therapeutics Q2 EPS $(0.27) Beats $(0.28) Estimate, Sales $57.00K Beat $20.00K Estimate

Onconova Therapeutics (NASDAQ:ONTX) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.28) by 3.57 percent. This is a 575 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $57.00 thousand which beat the analyst consensus estimate of $20.00 thousand by 185.00 percent. This is a 1.79 percent increase over sales of $56.00 thousand the same period last year.